Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

876 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessment of neutralizing antibody response as a correlate of protection against symptomatic SARS-CoV-2 infections after administration of two doses of the CoronaVac inactivated COVID-19 vaccine: A phase III randomized controlled trial.
Chen X, Meng X, Wu Q, Lim WW, Xin Q, Cowling BJ, Meng W, Yu H, Covasa DT. Chen X, et al. J Infect. 2024 Dec;89(6):106315. doi: 10.1016/j.jinf.2024.106315. Epub 2024 Oct 16. J Infect. 2024. PMID: 39423875 Free article. Clinical Trial.
Vaccine effects on in-hospital COVID-19 outcomes.
Gonçalves BP, Olliaro PL, Horby P, Cowling BJ. Gonçalves BP, et al. Among authors: cowling bj. Epidemiology. 2025 Jun 17. doi: 10.1097/EDE.0000000000001877. Online ahead of print. Epidemiology. 2025. PMID: 40525720
An overview of influenza H5 vaccines.
Taaffe J, Zhong S, Goldin S, Rawlings KS, Cowling BJ, Zhang W. Taaffe J, et al. Lancet Respir Med. 2025 Apr;13(4):e20-e21. doi: 10.1016/S2213-2600(25)00052-9. Epub 2025 Mar 13. Lancet Respir Med. 2025. PMID: 40090339 No abstract available.
Accomplishments and challenges in developing improved influenza vaccines: An evaluation of three years of progress toward the milestones of the influenza vaccines research and development roadmap.
Ostrowsky JT, Vestin NC, Mehr AJ, Ulrich AK, Bigalke L, Bresee JS, Friede MH, Gellin BG, Klugman KP, Nakakana UN, Wang TY, Weller CL, Osterholm MT, Lackritz EM, Moore KA; Influenza Vaccines R and D Roadmap Taskforce. Ostrowsky JT, et al. Vaccine. 2025 Jul 1;61:127431. doi: 10.1016/j.vaccine.2025.127431. Online ahead of print. Vaccine. 2025. PMID: 40602349 Free article. Review.
Corrigendum to Associations of reallocating sedentary leisure-time to alternative discretionary movement behaviours with incident cardiometabolic diseases in 0.5 million Chinese adults. The Lancet Regional Health-Western Pacific, Volume 57, 101524.
Collings PJ, Wang M, Ho HHS, Au Yeung SL, Siu PM, Cowling BJ, Sharp SJ, Brage S, Wareham NJ, Du H, Bennett DA, Kim Y. Collings PJ, et al. Lancet Reg Health West Pac. 2025 May 17;59:101580. doi: 10.1016/j.lanwpc.2025.101580. eCollection 2025 Jun. Lancet Reg Health West Pac. 2025. PMID: 40491987 Free PMC article.
876 results